Riskpilot← Back to searchSign inGet full accessKKS Medical AB
ABActiveOrg 5569462921Sikvägen 89Medical specialists activities · NACE 8622Est. 20130 employees
Revenue 2024
SEK 21K
+4% vs 2023
EBITDA margin
-17.5%
-134% vs 2023
Equity ratio
83.9%
Financial strength
Net profit 2024
SEK -5K
-157% vs 2023
| Revenue | SEK 21K | +4% |
| EBITDA | SEK -4K | -134% |
| Net profit | SEK -5K | -157% |
| Total assets | SEK 92K | +7% |
| Equity | SEK 77K | -5% |
| Employees | 0 | — |
Legal name
KKS Medical AB
Org number
5569462921
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
23 oktober 2013
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Företaget ska bedriva medicinsk konsultverksamhet och utfärdande av medicinska intyg.
Address
Sikvägen 89
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | — | 0 | 20 | 20 | 21 |
| Staff expenses | — | — | −5 | −0 | — |
| EBITDA | 0 | −12 | 8 | 11 | −4 |
| Depreciation & amort. | — | −1 | — | — | — |
| EBIT | 0 | −13 | 8 | 11 | −4 |
| Net financials | — | −1 | −0 | −0 | −0 |
| Profit before tax | 0 | −14 | 8 | 11 | −4 |
| Tax | — | −0 | — | −2 | −1 |
| Net profit | — | −14 | 8 | 8 | −5 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | — | 70 | 75 | 86 | 92 |
| Equity | — | 65 | 73 | 81 | 77 |
| Long-term debt | — | 0 | — | — | — |
| Short-term debt | — | 5 | 2 | 5 | 15 |
| Total debt | — | 5 | 2 | 5 | 15 |
EBITDA margin
-17.5%
This company
15.8%
Market median
-211% vs market
20202024
Equity ratio
83.9%
This company
38.2%
Market median
+120% vs market
20202024
Return on equity
-6.2%
This company
18.4%
Market median
-134% vs market
20202024
Net profit margin
-23.1%
This company
8.1%
Market median
-385% vs market
20202024
Asset turnover
0.22×
This company
1.12×
Market median
-80% vs market
20202024
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KKS Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristina Elisabet Stjerna | Deputy Board Member | 0 companies |
| Lars Gunnar Kristian Stjerna | Chairman | 0 companies |
| Karin Elisabet Stjerna | Board of Directors | 0 companies |